Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Examination of the external and internal load indicators' association with overuse injuries in professional soccer players.

Jaspers A, Kuyvenhoven JP, Staes F, Frencken WGP, Helsen WF, Brink MS.

J Sci Med Sport. 2018 Jun;21(6):579-585. doi: 10.1016/j.jsams.2017.10.005. Epub 2017 Oct 13.

PMID:
29079295
2.

How the concept of biochemical response influenced the management of primary biliary cholangitis over time.

Lammers WJ, Leeman M, Ponsioen CI, Boonstra K, van Erpecum KJ, Wolfhagen FH, Kuyvenhoven JP, Vrolijk JM, Drenth JP, Witteman EM, van Nieuwkerk CM, van der Spek BW, Witteman BJ, Erkelens GW, Verhagen MA, van Tuyl SA, Poen AC, Brouwer JT, Ter Borg F, Koek GH, van Ditzhuijsen TJ, Hansen BE; Dutch Multicenter PBC Study Group.

Neth J Med. 2016 Jul;74(6):240-6.

3.

An unusual cause of duodenal obstruction in adults.

Tack GJ, van Kelckhoven BJ, Kuyvenhoven JP.

Arab J Gastroenterol. 2015 Jun;16(2):63-5. doi: 10.1016/j.ajg.2015.03.002. Epub 2015 Apr 21.

PMID:
25910574
4.

Follow-up endoscopy for benign-appearing gastric ulcers has no additive value in detecting malignancy: It is time to individualise surveillance endoscopy.

Gielisse EA, Kuyvenhoven JP.

Gastric Cancer. 2015 Oct;18(4):803-9. doi: 10.1007/s10120-014-0433-4. Epub 2014 Oct 14.

PMID:
25312052
5.

[A women with an altered defaecation pattern].

Tack GJ, van Kelckhoven BJ, Kuyvenhoven JP.

Ned Tijdschr Geneeskd. 2013;157(41):A6501. Dutch.

PMID:
24103136
6.

Cost and quality-adjusted life year differences in the treatment of active ulcerative colitis using once-daily 4 g or twice-daily 2g mesalazine dosing.

Connolly MP, Kuyvenhoven JP, Postma MJ, Nielsen SK.

J Crohns Colitis. 2014 May;8(5):357-62. doi: 10.1016/j.crohns.2013.09.015. Epub 2013 Oct 2.

PMID:
24094599
7.

Randomised clinical trial: once- vs. twice-daily prolonged-release mesalazine for active ulcerative colitis.

Flourié B, Hagège H, Tucat G, Maetz D, Hébuterne X, Kuyvenhoven JP, Tan TG, Pierik MJ, Masclee AA, Dewit O, Probert CS, Aoucheta D; MOTUS study investigators.

Aliment Pharmacol Ther. 2013 Apr;37(8):767-75. doi: 10.1111/apt.12266. Epub 2013 Mar 4.

8.

Management of diverticulitis: results of a survey among gastroenterologists and surgeons.

de Korte N, Klarenbeek BR, Kuyvenhoven JP, Roumen RM, Cuesta MA, Stockmann HB.

Colorectal Dis. 2011 Dec;13(12):e411-7. doi: 10.1111/j.1463-1318.2011.02744.x.

PMID:
21819518
9.

Mild colonic diverticulitis can be treated without antibiotics. A case-control study.

de Korte N, Kuyvenhoven JP, van der Peet DL, Felt-Bersma RJ, Cuesta MA, Stockmann HB.

Colorectal Dis. 2012 Mar;14(3):325-30. doi: 10.1111/j.1463-1318.2011.02609.x.

PMID:
21689302
10.

Relatively high risk for hepatocellular carcinoma in patients with primary biliary cirrhosis not responding to ursodeoxycholic acid.

Kuiper EM, Hansen BE, Adang RP, van Nieuwkerk CM, Timmer R, Drenth JP, Spoelstra P, Brouwer HT, Kuyvenhoven JP, van Buuren HR; Dutch PBC Study Group.

Eur J Gastroenterol Hepatol. 2010 Dec;22(12):1495-502. doi: 10.1097/MEG.0b013e32834059e7.

PMID:
21389798
11.

Eruptive benign melanocytic naevi during immunosuppressive therapy in a Crohn's disease patient.

de Boer NK, Kuyvenhoven JP.

Inflamm Bowel Dis. 2011 Jun;17(6):E26. doi: 10.1002/ibd.21618. Epub 2011 Feb 1. No abstract available.

PMID:
21287668
12.

Harmonisation of TB control in the WHO European region: the history of the Wolfheze Workshops.

Veen J, Migliori GB, Raviglione M, Rieder HL, Dara M, Falzon D, Kuyvenhoven JV, Schwoebel V, Zaleskis R.

Eur Respir J. 2011 Apr;37(4):950-9. doi: 10.1183/09031936.00019410. Epub 2010 Jun 7.

13.

A tough case to swallow: esophageal intramural pseudodiverticulosis.

de Boer NK, Peters JH, Kuyvenhoven JP.

J Gastrointestin Liver Dis. 2009 Dec;18(4):513. No abstract available.

14.

Rectal Meckel's diverticulum.

de Boer NK, Kuyvenhoven JP.

Endoscopy. 2009;41 Suppl 2:E258. doi: 10.1055/s-0029-1214696. Epub 2009 Sep 28. No abstract available.

PMID:
19787581
15.

Primary herpes simplex type 1 esophagitis followed by recurrent perianal herpetic infection in an immunocompetent host.

de Boer NK, van Krimpen C, Kuyvenhoven JP.

Am J Gastroenterol. 2009 Jul;104(7):1858-9. doi: 10.1038/ajg.2009.193. Epub 2009 May 19. No abstract available.

PMID:
19455123
16.

Diagnosis and treatment of tuberculosis in undocumented migrants in low- or intermediate-incidence countries.

Heldal E, Kuyvenhoven JV, Wares F, Migliori GB, Ditiu L, Fernandez de la Hoz K, Garcia D.

Int J Tuberc Lung Dis. 2008 Aug;12(8):878-88.

PMID:
18647446
17.

[Large-scale outbreak investigation for tuberculosis in Zeist].

Kuyvenhoven JV, Cobelens FG.

Ned Tijdschr Geneeskd. 2005 Aug 27;149(35):1925-8. Dutch.

PMID:
16159028
18.

Preanalytical conditions and circulating matrix metalloproteinases.

Verspaget HW, Kuyvenhoven JP, van Hoek B.

Transplantation. 2005 Mar 27;79(6):745-6. No abstract available.

PMID:
15785393
19.

The estimation of renal transit using renography--our opinion.

Kuyvenhoven JD, Ham HR, Piepsz A.

Nucl Med Commun. 2004 Dec;25(12):1223-31.

PMID:
15640783
20.

Assessment of serum matrix metalloproteinases MMP-2 and MMP-9 after human liver transplantation: increased serum MMP-9 level in acute rejection.

Kuyvenhoven JP, Verspaget HW, Gao Q, Ringers J, Smit VT, Lamers CB, van Hoek B.

Transplantation. 2004 Jun 15;77(11):1646-52.

PMID:
15201662
21.

The influence of renal function on normalized residual activity.

Kuyvenhoven JD, Ham HR, Piepsz A.

Nucl Med Commun. 2004 Feb;25(2):151-4.

PMID:
15154704
22.

Recovery of renal retention function by differentiating the Patlak-Rutland plot.

Kuyvenhoven JD, Ham HR, Piepsz A.

Nucl Med Commun. 2004 May;25(5):501-7.

PMID:
15100510
23.

Database deconvolution.

Kuyvenhoven JD, Ham HR, Piepsz A.

Nucl Med Commun. 2004 Jan;25(1):87-8. No abstract available.

PMID:
15061270
24.

Plasma MMP-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 during human orthotopic liver transplantation. The effect of aprotinin and the relation to ischemia/reperfusion injury.

Kuyvenhoven JP, Molenaar IQ, Verspaget HW, Veldman MG, Palareti G, Legnani C, Moolenburgh SE, Terpstra OT, Lamers CB, van Hoek B, Porte RJ.

Thromb Haemost. 2004 Mar;91(3):506-13.

PMID:
14983226
26.

Serum matrix metalloproteinase MMP-2 and MMP-9 in the late phase of ischemia and reperfusion injury in human orthotopic liver transplantation.

Kuyvenhoven JP, Ringers J, Verspaget HW, Lamers CB, van Hoek B.

Transplant Proc. 2003 Dec;35(8):2967-9.

PMID:
14697951
27.

Current status and future plans of Nuclear Medicine Procedure Guidelines in Central and Eastern European EANM member societies compared with those in other EANM member societies.

Kuyvenhoven JD, Plachcińska A, Lass P, van Rijk P, Dierckx RA; European Association of Nuclear Medicine Task Force on Quality Assurance and Standardisation.

Nucl Med Rev Cent East Eur. 2000;3(2):115-25.

PMID:
14600904
28.

Optimal time window for measurement of renal output parameters.

Kuyvenhoven JD, Ham HR, Piepsz A.

Nucl Med Rev Cent East Eur. 2002;5(2):105-8.

PMID:
14600867
29.

99mTc-MAG3 diuretic renography in children: a comparison between F0 and F+20.

Donoso G, Kuyvenhoven JD, Ham H, Piepsz A.

Nucl Med Commun. 2003 Nov;24(11):1189-93.

PMID:
14569174
30.

[Centenary of the Royal Dutch Central Association for the Prevention of Tuberculosis].

Kuyvenhoven JV, Broekmans JF.

Ned Tijdschr Geneeskd. 2003 Sep 20;147(38):1869-74. Dutch. Erratum in: Ned Tijdschr Geneeskd. 2003 Dec 27;147(52):2612.

PMID:
14533502
31.

Calculation of renal retention function without deconvolution.

Kuyvenhoven JD, Ham HR, Piepsz A.

Nucl Med Commun. 2003 Oct;24(10):1097-103.

PMID:
14508166
32.

When could the administration of furosemide be avoided?

Kuyvenhoven J, Piepsz A, Ham H.

Clin Nucl Med. 2003 Sep;28(9):732-7.

PMID:
12972994
33.

Assessment of the clinical significance of serum matrix metalloproteinases MMP-2 and MMP-9 in patients with various chronic liver diseases and hepatocellular carcinoma.

Kuyvenhoven JP, van Hoek B, Blom E, van Duijn W, Hanemaaijer R, Verheijen JH, Lamers CB, Verspaget HW.

Thromb Haemost. 2003 Apr;89(4):718-25.

PMID:
12669127
34.

Influence of renal function on renal output efficiency.

Kuyvenhoven JD, Ham HR, Piepsz A.

J Nucl Med. 2002 Jun;43(6):851-5.

35.

Normalized residual activity: usual values and robustness of the method.

Piepsz A, Kuyvenhoven JD, Tondeur M, Ham H.

J Nucl Med. 2002 Jan;43(1):33-8.

36.

Practical management of hepatocellular carcinoma.

Kuyvenhoven JPh, Lamers CB, van Hoek B.

Scand J Gastroenterol Suppl. 2001;(234):82-7. Review.

PMID:
11768566
37.

Is deconvolution applicable to renography?

Kuyvenhoven JD, Ham H, Piepsz A.

Nucl Med Commun. 2001 Nov;22(11):1255-60.

PMID:
11606893
38.

Motor and sensory function of the rectum in different subtypes of constipation.

Penning C, Steens J, van der Schaar PJ, Kuyvenhoven J, Delemarre JB, Lamers CB, Masclee AA.

Scand J Gastroenterol. 2001 Jan;36(1):32-8.

PMID:
11218237
39.

European Medical Device Directive: impact on nuclear medicine.

Kuyvenhoven JD, Lahorte P, Persyn K, De Geest E, van Loon PW, Jacobs F, van Rijk PP, Lemahieu I, Dierckx RA.

Comput Med Imaging Graph. 2001 Mar-Apr;25(2):207-12.

PMID:
11137798
40.

A survey of guidelines in 27 EANM associated societies by the EANM Task Group on Quality Assurance and Standardisation. European Association of Nuclear Medicine.

Kuyvenhoven JD, Busemann Sokole E, van Rijk P, Clausen M, Jamar F, Slegers G, Thierens H, Cosgriff P, Dierckx RA.

Eur J Nucl Med. 2000 Oct;27(10):BP31-44. Erratum in: Eur J Nucl Med 2000 Dec;27(12):BP48.

PMID:
11083551
41.

Expert groups, task groups and committees, national societies and the nuclear medicine community: towards "EANM protocols". European Association of Nuclear Medicine.

Kuyvenhoven JD, Busemann Sokole E, van Rijk P, Dierckx RA.

Eur J Nucl Med. 2000 Oct;27(10):1437-40. No abstract available.

PMID:
11083531
42.

Peptic ulcer bleeding: interaction between non-steroidal anti-inflammatory drugs, Helicobacter pylori infection, and the ABO blood group system.

Kuyvenhoven JP, Veenendaal RA, Vandenbroucke JP.

Scand J Gastroenterol. 1999 Nov;34(11):1082-6.

PMID:
10582757
43.

[The organization and implementation of influenza vaccination in Groningen, 1993-1996].

Luinstra-Passchier MJ, Broer J, Tent B, Kuyvenhoven JV.

Ned Tijdschr Geneeskd. 1998 May 23;142(21):1202-6. Dutch.

PMID:
9627453
44.

[Tuberculosis in asylum seekers in The Netherlands].

Kuyvenhoven JV, Lambregts-van Weezenbeek CS, Année-van Bavel JA.

Ned Tijdschr Geneeskd. 1997 Mar 22;141(12):581-4. Dutch.

PMID:
9190525
45.

Graves' dermopathy: does octreotide scintigraphy predict the response to octreotide treatment?

Kuyvenhoven JP, van der Pijl JW, Goslings BM, Wiersinga WM.

Thyroid. 1996 Oct;6(5):385-9.

PMID:
8936660
46.

Lung uptake on technetium-99m-MDP bone scan in Wegener's vasculitis.

Kuyvenhoven JD, Ommeslag DJ, Ackerman CM, Hilderson JM, Troch ME.

J Nucl Med. 1996 May;37(5):857-8.

47.

Thallium-201 accumulation in myositis ossificans and in juxta-articular ossification.

Osmanagaoglu K, Kuyvenhoven J, Dierckx RA, Hamers J, Cuvelier C, Uyttendaele D, Simons M.

J Nucl Med. 1995 Dec;36(12):2239-42.

48.

Abnormal uptake of Tc-99m HIG in hematomas.

Kuyvenhoven J, De Rycke J, Crombez R.

Clin Nucl Med. 1995 Aug;20(8):727-8. No abstract available.

PMID:
7586880
49.

Role of tolerance in treatment and prophylaxis of experimental Staphylococcus aureus endocarditis with vancomycin, teicoplanin, and daptomycin.

Voorn GP, Kuyvenhoven J, Goessens WH, Schmal-Bauer WC, Broeders PH, Thompson J, Michel MF.

Antimicrob Agents Chemother. 1994 Mar;38(3):487-93.

50.

Prosthetic valve endocarditis: analysis of risk factors for mortality.

Kuyvenhoven JP, van Rijk-Zwikker GL, Hermans J, Thompson J, Huysmans HA.

Eur J Cardiothorac Surg. 1994;8(8):420-4.

PMID:
7986559

Supplemental Content

Loading ...
Support Center